Related Experiment Video
Updated: Oct 8, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Transcobalamin receptor deficiency in seven asymptomatic patients ascertained through newborn screening
Kara B Pappas1,2, Marissa Younan1, Robert Conway1
1Department of Genetics, Genomics, and Metabolic Disorders, Children's Hospital of Michigan, Detroit, Michigan, USA.
Insights
Transcobalamin receptor deficiency (TCRD) appears to be a benign condition with normal growth and development in affected children. Early biochemical abnormalities normalize with treatment, suggesting TCRD may be an incidental newborn screening finding.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Transcobalamin receptor deficiency (TCRD) is a rare genetic disorder affecting vitamin B12 metabolism.
- Newborn screening programs identify biochemical abnormalities associated with various metabolic disorders.
Purpose of the Study:
- To describe the clinical course and outcomes of seven patients with TCRD.
- To evaluate the significance of TCRD as identified by newborn screening.
Main Methods:
- Retrospective case series analysis of seven patients diagnosed with TCRD.
- Review of clinical data, growth parameters, and biochemical markers.
- Comparison of TCRD incidence with other inborn errors of metabolism.
Main Results:
- All seven patients exhibited normal growth and development without health issues or metabolic decompensation.
- Biochemical abnormalities normalized following parenteral hydroxocobalamin treatment.
- TCRD incidence appears comparable to other C3 acylcarnitine-elevating disorders.
Conclusions:
- TCRD presents as a generally benign condition with favorable long-term outcomes in the observed cases.
- TCRD may be considered an incidental finding on newborn screening, warranting further long-term outcome studies.
Abstract:
We report seven cases from our clinic with transcobalamin receptor deficiency (TCRD). None of our cases have experienced health issues or metabolic decompensation. All have experienced typical growth and development throughout childhood, with our oldest case now 10 years old. Every case has had normalization of initial biochemical abnormalities following parenteral hydroxocobalamin administration. Several cases had trace elevations of methylmalonic acid throughout childhood, all which normalized without further hydroxocobalamin administration. Population data from our state's newborn screening program suggest the incidence of TCRD is comparable to other metabolic disorders associated with elevations of C3 acylcarnitine including propionic academia, isolated methylmalonic academia and combined methylmalonic academia and hyperhomocysteinemia due to cobalamin metabolism disorders. Based on the generally benign nature of this condition, we assert that TCRD may be considered an incidental finding on newborn screen. However, additional long-term data are needed to ascertain the long term outcomes of children identified with TCRD.
Related Concept Videos
Inborn Errors of Metabolism
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Rh Blood Group

